Scroll Top
Gain Therapeutics Inc.

Gain Therapeutics stock advances as Phase 1b trial enrollment exceeds expectations

Investing.com

Jul 03, 2025

Gain Therapeutics stock advances as Phase 1b trial enrollment exceeds expectations

Latest Articles

Clear Filters
December 18, 2025
Two Molecules Show Potential in Targeting GCase Activity for Parkinson’s Disease Treatment
https://www.geneonline.com/two-molecules-show-potential-in-targeting-gcase-activity-for-parkinsons-disease-treatment/
Read More
December 13, 2025
AI and Physics-Based Modeling Identifies a New Parkinson’s Disease Drug
https://www.the-scientist.com/ai-and-physics-based-modeling-identifies-a-new-parkinson-s-disease-drug-73851
Read More
October 9, 2025
In the clinic for Oct. 9, 2025
https://www.bioworld.com/articles/724982-in-the-clinic-for-oct-9-2025
Read More